Work

Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance

Year: 2009

Type: article

Abstract: Monoclonal gammopathy of undetermined significance (MGUS) is one of the most common pre-malignant disorders in western countries with a prevalence of 3.2% in the Caucasian general population 50 years of age or older.[1][1] It is characterized by the presence of a monoclonal immunoglobulin (M-protein

Source: Haematologica

DOI: 10.3324/haematol.2009.006346

Authors: S. Y. Kristinsson, L. R. Goldin, M. Bjorkholm, I. Turesson, O. Landgren

Institution: University Hospital Carl Gustav Carus

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157